Skip to content

Tengjun Biotechnology Corp.

company.status.inactive

CIK 1499785fmd_09V5WENWQ2Z1J5J9XE1REN9GXSManufacturing · BeveragesTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2023, 52 periods

Latest annual · FY2022

Millions
Total revenues
150
Gross profit
140
Operating income
16
Net income
11
Free cash flow
1

Latest quarter · Q2 FY2023

Millions
Total revenues
0
Gross profit
(0)
Operating income
(0)
Net income
(0)
Free cash flow
7
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
n/m
Revenue, 5 yearsFY2017 to FY2022
n/m
Net income, 5 yearsFY2017 to FY2022
n/m

Tengjun Biotechnology Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$150.1 million10-K 2023-04-17 · proof
Gross profit$140.4 million10-K 2023-04-17 · proof
Operating income$16.1 million-$738,23410-K 2023-04-17 · proof
Net income$11.3 million-$747,52510-K 2023-04-17 · proof
Cash from operating activities$1.3 million-$561,29710-K 2023-04-17 · proof
Free cash flow$1.3 million-$629,83310-K 2023-04-17 · proof
Total assets$58.6 million$14 million+317.9%10-K 2023-04-17 · proof
Total liabilities$43.7 million$16.3 million+167.6%10-K 2023-04-17 · proof
Cash and cash equivalents$2.8 million$285,568+891.2%10-K 2023-04-17 · proof
What was Tengjun Biotechnology Corp.'s revenue in fiscal 2022?
Tengjun Biotechnology Corp. reported revenue of $150.1 million for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was Tengjun Biotechnology Corp.'s gross profit in fiscal 2022?
Tengjun Biotechnology Corp. reported gross profit of $140.4 million for fiscal 2022 (the year ended Dec 31, 2022). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was Tengjun Biotechnology Corp.'s operating income in fiscal 2022?
Tengjun Biotechnology Corp. reported operating income of $16.1 million for fiscal 2022 (the year ended Dec 31, 2022), against -$738,234 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was Tengjun Biotechnology Corp.'s net income in fiscal 2022?
Tengjun Biotechnology Corp. reported net income of $11.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$747,525 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was Tengjun Biotechnology Corp.'s cash from operating activities in fiscal 2022?
Tengjun Biotechnology Corp. reported cash from operating activities of $1.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$561,297 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What was Tengjun Biotechnology Corp.'s free cash flow in fiscal 2022?
Tengjun Biotechnology Corp. reported free cash flow of $1.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$629,833 the year before. Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What are Tengjun Biotechnology Corp.'s total assets?
As of Dec 31, 2022, Tengjun Biotechnology Corp. reported total assets of $58.6 million, against $14 million a year earlier (+317.9%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What are Tengjun Biotechnology Corp.'s total liabilities?
As of Dec 31, 2022, Tengjun Biotechnology Corp. reported total liabilities of $43.7 million, against $16.3 million a year earlier (+167.6%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC
What are Tengjun Biotechnology Corp.'s cash and cash equivalents?
As of Dec 31, 2022, Tengjun Biotechnology Corp. reported cash and cash equivalents of $2.8 million, against $285,568 a year earlier (+891.2%). Source: the 10-K filed with the SEC on Apr 17, 2023. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1499785&period_type=annual&limit=5"

Information only, not investment advice.